Radcliffe Capital Management’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-623,267
Closed -$6.76M – 456
2026
Q1
$6.76M Buy
623,267
+50,045
+9% +$539K 0.51% 27
2025
Q4
$6.13M Buy
573,222
+327
+0.1% +$3.49K 0.33% 52
2025
Q3
$6.07M Buy
572,895
+425,152
+288% +$4.5M 0.38% 32
2025
Q2
$1.56M Buy
+147,743
New +$1.54M 0.12% 91

Other funds holding GPAT

Radcliffe Capital Management's GPAT Position: Q2 2026 in Review

Radcliffe Capital Management sold out of GP-Act III Acquisition Corp (GPAT) in Q2 2026, closing a stake of 623,267 shares — an estimated $6.76M sold.

Radcliffe Capital Management first reported a position in GPAT in Q2 2025 and held it in 4 quarters. The position peaked at $6.76M in Q1 2026. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • Radcliffe Capital Management reported no remaining GP-Act III Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Radcliffe Capital Management sold 623,267 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $6.76M.
  • Radcliffe Capital Management first reported a position in GP-Act III Acquisition Corp in Q2 2025 and held it in 4 quarters.
  • Radcliffe Capital Management's GP-Act III Acquisition Corp position peaked at $6.76M in Q1 2026.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on Radcliffe Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.